Trident Lifeline touches roof on getting nod to acquire 51% stake in TLL Herbal
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Trident Lifeline is locked its upper circuit limit at Rs. 160.20, up by 26.70 points or 20.00% from its previous closing of Rs. 133.50 on the BSE.
The scrip opened at Rs. 146.00 and has touched a high and low of Rs. 160.20 and Rs. 146.00 respectively. So far 20400 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 179.95 on 24-Oct-2022 and a 52 week low of Rs. 102.75 on 11-Oct-2022.
Last one week high and low of the scrip stood at Rs. 160.20 and Rs. 131.00 respectively. The current market cap of the company is Rs. 153.51 crore.
The promoters holding in the company stood at 70.04%, while Institutions and Non-Institutions held 4.36% and 25.60% respectively.
Trident Lifeline has received approval for acquisition of majority stake (51%) in TLL Herbal from the existing shareholders of TLL Herbal, making it Subsidiary of the Company. The objective of acquisition is to expand the business towards new technologies by establishing a Research & Development cum production facility along with integration facility. The Board of Directors, at their meeting held on July 15, 2023, has transacted, approved the same.
Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.
